// App-Quantinova.ai

303 : The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

Researchers

Presenter

  • Paul R. Yenson

Principal Investigators

  • Tamara Shenkier

  • Laurie H. Sehn

  • Richard Klasa

  • Diego Villa

  • Ozge Goktepe

  • Outcomes

  • Christian Steidl

  • Graham W. Slack

  • Randy D. Gascoyne

  • Joseph M. Connors

Medical Centers

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Cancer Surveillance & Department of Internal Medicine, Division of Hematology, University of British Columbia, Vancouver, BC,

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Solid malignancies

  • Diffuse large B-cell lymphoma

Biomarkers

  • Estrogen receptor alpha

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • randomized

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved